Cite
APA Citation
Klaassen, Z., Singh, A. A., Howard, L. E., Feng, Z., Trock, B., Terris, M. K., Aronson, W. J., Cooperberg, M. R., Amling, C. L., Kane, C. J., Partin, A., Han, M., & Freedland, S. J. (2015). is clinical stage T2c prostate cancer an intermediate‐ or high‐risk disease?. Cancer, 121(9), 1414–1421. http://access.bl.uk/ark:/81055/vdc_100089227995.0x000063